ArticleBiotechnology reports (Amsterdam, Netherlands)2025

Prioritizing repurposable drugs for Alzheimer's disease using network-based analysis with concurrent assessment of Long QT syndrome risk.

Alessio Funari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.